Cepa Program is categorized under Infectious Disease Specialists in Holyoke, MA and active since 1989.
Cepa Program was established in 1989, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Infectious Disease Specialists business, which does work in the B2C market, and is classified as a Infectious Disease Specialists, under code number 6219992 by the NAICS.
If you are seeking more information, feel free to contact Daniela Falvo, Executive Director at the company’s single location by writing to 330 Appleton St, Holyoke, Massachusetts MA 01040 or by phoning (413) 536-8721. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Cepa Program |
| Contact Person: | Daniela Falvo, Executive Director |
| Address: | 330 Appleton St, Holyoke, Massachusetts 01040 |
| Phone Number: | (413) 536-8721 |
| Annual Revenue (USD): | $1.000.000 to $2.499.999 |
| Founded: | 1989 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Infectious Disease Specialists |
| SIC Code: | 8011 |
| NAICS Code: | 6219992 |
| Share This Business: |
Cepa Program was started in 1989 to provide professional Infectious Disease Specialists under the SIC code 8011 and NAICS code 6219992. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.
Feel free to contact Daniela Falvo, Executive Director for inquiries that concern Cepa Program by calling the company number (413) 536-8721, as your correspondence is most welcome. Additionally, the physical location of the single location of Cepa Program can be found at the coordinates 42.20568,-72.61135 as well as the street address 330 Appleton St in Holyoke, Massachusetts 01040.
For its online presence, you may visit Cepa Program’s website at and engage with its social media outlets through on Twitter and on Facebook.